Patents by Inventor Robson de Queiroz Monteiro

Robson de Queiroz Monteiro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis
    Patent number: 9272023
    Abstract: The invention provides methods for treatment of tissue factor (TF) mediated or associated diseases or processes, such as cancer, by administering at least an active fragment of an Ixolaris polypeptide to a subject. The invention further includes identification of a subject in need of such treatment, and monitoring a subject for amelioration of at least one sign or symptom of the disease. The invention also features kits.
    Type: Grant
    Filed: May 30, 2014
    Date of Patent: March 1, 2016
    Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: Ivo M. Francischetti, Robson de Queiroz Monteiro, Jose Marcos C. Ribeiro
  • USE OF IXOLARIS, A TISSUE FACTOR INHIBITOR, FOR THE TREATMENT AND PREVENTION OF CANCER
    Publication number: 20140342987
    Abstract: The invention provides methods for treatment of tissue factor (TF) mediated or associated diseases or processes, such as cancer, by administering at least an active fragment of an Ixolaris polypeptide to a subject. The invention further includes identification of a subject in need of such treatment, and monitoring a subject for amelioration of at least one sign or symptom of the disease. The invention also features kits.
    Type: Application
    Filed: May 30, 2014
    Publication date: November 20, 2014
    Inventors: Ivo M. Francischetti, Robson de Queiroz Monteiro, Jose Marcos C. Ribeiro
  • Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
    Patent number: 8772238
    Abstract: The invention provides methods for treatment of tissue factor (TF) mediated or associated diseases or processes, such as cancer, by administering at least an active fragment of an Ixolaris polypeptide to a subject. The invention further includes identification of a subject in need of such treatment, and monitoring a subject for amelioration of at least one sign or symptom of the disease. The invention also features kits.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: July 8, 2014
    Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
    Inventors: Ivo M. B. Francischetti, Robson de Queiroz Monteiro, Jose Marcos C. Ribeiro
  • USE OF IXOLARIS, A TISSUE FACTOR INHIBITOR, FOR THE TREATMENT AND PREVENTION OF CANCER
    Publication number: 20120010137
    Abstract: The invention provides methods for treatment of tissue factor (TF) mediated or associated diseases or processes, such as cancer, by administering at least an active fragment of an Ixolaris polypeptide to a subject. The invention further includes identification of a subject in need of such treatment, and monitoring a subject for amelioration of at least one sign or symptom of the disease. The invention also features kits.
    Type: Application
    Filed: March 18, 2010
    Publication date: January 12, 2012
    Inventors: Ivo M.B. Francischetti, Robson de Queiroz Monteiro, Jose Marcos C. Ribeiro